NTN4 has been implicated in activating multiple oncogenic pathways in gastric cancer, namely Jak/Stat, PI3K/Akt and ERK/MAPK [63], and it interacts with integrin β4 to promote glioblastoma cell proliferation via the AKT-mTor pathway [56]. The gene discussed is MTOR; the disease is gastric cancer.